Dick and Betsy Devos Struggle to Find Candidate

Dick DeVos has previously expressed his interest in the campaign of Florida Senator Marco Rubio. The reason he gave for his support of the Florida Senator was that he believed that the senator represented true conservative values and had fresh ideas for the party. Dick Devos’ support of Marco Rubio caused the senator’s campaign to gain traction, but ultimately the senators could not continue to make a bid for president if he could not win in his own state of Florida. Marco Rubio lost the republican presidential primary in Florida to Donald Trump, who won 46% of the vote. Although it seems that half of the state was supporting Donald Trump and the other half did not, the other republican nominees divided the votes in Florida, leaving Rubio with only 26% of the vote.
Since Rubio and other Republican Nominees have left the GOP race, the Devos family has had difficulty choosing a campaign to support. The remaining candidates for the republican nomination are Ted Cruz and Donald Trump. While Ted Cruz is expected to take the majority of the evangelical right wing vote, Donald Trump is expected to win the nomination. Because these candidates do not seem to represent the values that Dick Devos finds important, he has had trouble finding a candidate to back. Though he has expressed his unwavering support of the Republican party, Dick Devos has stated that he will not be funding any major republican presidential campaigns at this time.
The Devos family has stated that they will continue to support the Republican Party on a large scale, regardless of their disdain for the current nominees. Dick Devos has expressed his opinion that regardless of the particular candidate that represents the party’s presidential nomination, he believes that the conservative party holds great ideas that will drastically improve the country. As a man who has a history of activity in the political arena, Dick Devos has seen his share of politicians come and go. He has remained dedicated to the conservative cause for many decades. Both Dick Devos and his wife Betsy have recently stated that they will support the republican nominee for president by attending events and raising awareness even if they are not financially involved in the campaign.

An In-Depth Look Into The Progress And Achievements Of Seattle Genetics

The 2016 Seattle Genetics’ Financial Results Conference, which was directed by Corporate Communications Executive Director, Peggy Pinkston, highlighted the several achievements the company has made in the second quarter of the 2016 financial year. The items brought up for discussion included statements touching on the future financial events that may impact the financial performance of the company as well as enhancing conformity with the regulations offered by the SEC.

 The form highlights some of the risk factors that could trigger actual results to differ from the ones present in forward-looking statements.

A word from the Chairman, Clay B. Siegall
The Executive Director of Communications finally handed over the debate to the Chairman, Clay Siegall, for closing remarks and for information about the financial progress of the company to this point. Clay B. Siegall emphasized in the need to build ADCETRIS to become an internationally accepted brand while also enhancing innovation and profitability for the company. He commended the progress of the company on this product and expressed hope in the creation of more products to accompany their mission on revolutionizing biotechnology.

Clay B. Siegall proceeded with his speech and noted the much progress they have made as a company in ensuring antitumor activity from the different ADCs they have released to the market is enhanced.  In the second quarter alone, Seattle Genetics made $95.4 million in revenues, which included $66.2 million net revenue from ADCETRIS.

About Seattle Genetics and Chairman Clay B. Siegall
Seattle Genetics is a leading biotechnology firm that focuses on the development of antibody-based therapies that are useful in the treatment of cancer. The company, which is led by CEO and Board Chairman Clay B. Siegall, is among few that have introduced clinical trials and innovative technology.

Clay B. Siegall is a co-founder of Seattle Genetics and has been steering the company since its establishment in 1998. He is a scientist by training and his main areas of focus are cancer therapies. Clay B. Siegall has created a scientific foundation for Seattle Genetics and has encouraged rigorous research and product development practices.

Original Sources: